Alcohol and cannabis: Comparing their adverse health effects and regulatory regimes

International Journal of Drug Policy

Volumn 42, Issue , 2017, Pages 57-62

  Hall, Wayne ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Adverse health effects; Alcohol; Cannabis; Regulatory regime

Indexed keywords

ILLICIT DRUG; ALCOHOL; CANNABIS;

ALCOHOL CONSUMPTION; ARTICLE; CANNABIS ADDICTION; CANNABIS USE; CARDIOVASCULAR RISK; COGNITIVE DEFECT; COMPARATIVE STUDY; CORRELATIONAL STUDY; DRUG MARKETING; GOVERNMENT REGULATION; HEALTH HAZARD; HUMAN; LEGAL ASPECT; PSYCHOSIS; PUBLIC HEALTH; RISK ASSESSMENT; SCHOOL DROPOUT; SUBSTANCE USE; CHEMICALLY INDUCED; DRUG CONTROL;

CANNABIS; COGNITIVE DYSFUNCTION; DRUG AND NARCOTIC CONTROL; ETHANOL; HUMANS; PSYCHOSES, SUBSTANCE-INDUCED;

EID: 85007387730     PISSN: 09553959     EISSN: 18734758     Source Type: Journal    
DOI: 10.1016/j.drugpo.2016.10.021     Document Type: Article

References (94)

1. Anthony, J., The epidemiology of cannabis dependence. Roffman, R.A., Stephens, R.S., (eds.) Cannabis dependence: Its nature, consequences and treatment, 2006, Cambridge University Press, Cambridge, 58–105.
2. Anthony, J., Warner, L., Kessler, R., Comparative epidemiology of dependence on tobacco, alcohol, controlled substances and inhalants: Basic findings from the National Comorbidity Survey. Experimental and Clinical Psychopharmacology 2 (1994), 244–268.
3. Asbridge, M., Hayden, J.A., Cartwright, J., Acute cannabis consumption and motor vehicle collision risk: Systematic review of observational studies and meta-analysis. BMJ 344 (2012), 14–17.
4. Auer, R., Vittinghoff, E., Yaffe, K., Kunzi, A., Kertesz, S.G., Levine, D.A., et al. Association between lifetime marijuana use and cognitive function in middle age: The Coronary Artery Risk Development in Young Adults (CARDIA) Study. JAMA Internal Medicine 176 (2016), 352–361.
5. Babor, T., Caetano, R., Casswell, S., Edwards, G., Giesbrecht, N., Graham, K., et al. Alcohol: No ordinary commodity: Research and public policy. 2nd ed., 2010, Oxford University Press, Oxford.
6. Bachman, J., Wadsworth, K., O'Malley, P., Johnston, L., Schulenberg, J., Smoking, drinking, and drug use in young adulthood: The impacts of new freedoms and new responsibilities. 1997, Lawrence Erlbaum, Mahwah, NJ.
7. Backinger, C.L., Fagan, P., Matthews, E., Grana, R., Adolescent and young adult tobacco prevention and cessation: Current status and future directions. Tobacco Control 12:Suppl. 4 (2003), Iv46–Iv53.
8. BBC, Barack Obama: ‘Marijuana no more dangerous than alcohol’: US President Barack Obama has said smoking marijuana is no more dangerous than alcohol, but still called it a ‘bad idea’. 2014, BBC News 20 January. Retrieved 20 May 2015 from http://www.bbc.com/news/world-us-canada-25805206.
9. Boffey, P.M., Editorial: What science says about marijuana. 2014, New York Times July 30. Retrieved 20 May 2015 from http://www.nytimes.com/2014/07/31/opinion/what-science-says-about-marijuana.html?_r=0.
10. Burns, R.M., Caulkins, J.P., Everingham, S.S., Kilmer, B., Statistics on cannabis users skew perceptions of cannabis use. Frontiers in Psychiatry, 4, 2013, 138.
11. Caulkins, J.P., The real dangers of marijuana. National Affairs 26 (2016), 21–24.
12. Cerdá, M., Moffitt, T.E., Meier, M., Harrington, H., Houts, R., Ramrakha, S., et al. Persistent cannabis dependence and alcohol dependence represent risks for midlife economic and social problems: A longitudinal cohort study. Clinical Psychological Science(March), 2016, 10.1177/2167702616630958.
13. Cermak, T.L., Banys, P., Prevention of youthful marijuana use. Journal of Psychoactive Drugs 48 (2016), 21–23.
14. Connor, J.P., Haber, P.S., Hall, W.D., Alcohol use disorders. Lancet 387 (2016), 988–998.
15. Crombie, N., Oregon marijuana edibles makers launch public campaign: ‘Try 5’. 2016, The Oregonian/Oregon Live May 25. Retrieved 14 June 2016 from http://www.oregonlive.com/marijuana/index.ssf/2016/05/oregon_marijuana_edibles_maker.html.
16. Degenhardt, L., Hall, W.D., What are the policy implications of the evidence on cannabis and psychosis?. Castle, D., Murray, R., D'Souza, D., (eds.) Marijuana and madness, 2nd ed., 2012, Cambridge University Press, New York, 55–65.
17. Degenhardt, L., Hall, W.D., Lynskey, M., McGrath, J., McLaren, J., Calabria, B., Vos, T., Should burden of disease estimates include cannabis use as a risk factor for psychosis?. PLoS Medicine, 6, 2009, 7.
18. Di Forti, M., Marconi, A., Carra, E., Fraietta, S., Trotta, A., Bonomo, M., et al. Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: A case-control study. Lancet Psychiatry 2 (2015), 233–238.
19. Editorial Board of the New York Times, Repeal Prohibition, again. 2014, New York Times Retrieved 20 May 2016 from http://www.nytimes.com/interactive/2014/07/27/opinion/sunday/high-time-marijuana-legalization.html?_r=0#.
20. EMCDDA, Drug treatment overview for Netherlands. 2013, European Monitoring Centre for Drugs and Drug Addiction, Lisbon Retrieved 23 July 2014 from http://www.emcdda.europa.eu/data/treatment-overviews/Netherlands.
21. Fergusson, D., Boden, J., Cannabis use and later life outcomes. Addiction 103 (2008), 969–976 discussion 977–968.
22. Fergusson, D., Boden, J., Horwood, L., Cannabis use and other illicit drug use: Testing the cannabis gateway hypothesis. Addiction 101 (2006), 556–569.
23. Fergusson, D., Boden, J., Horwood, L., The developmental antecedents of illicit drug use: Evidence from a 25-year longitudinal study. Drug and Alcohol Dependence 96 (2008), 165–177.
24. Forouzanfar, M.H., Alexander, L., Anderson, H.R., Bachman, V.F., Biryukov, S., Brauer, M., et al. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet 386 (2015), 2287–2323.
25. Freeman, T.P., Winstock, A.R., Examining the profile of high-potency cannabis and its association with severity of cannabis dependence. Psychological Medicine 45 (2015), 3181–3189.
26. Gable, R.S., Comparison of acute lethal toxicity of commonly abused psychoactive substances. Addiction 99 (2004), 686–696.
27. Gates, P.J., Sabioni, P., Copeland, J., Le Foll, B., Gowing, L., Psychosocial interventions for cannabis use disorder. Cochrane Database of Systematic Reviews, 5, 2016, CD005336.
28. Hall, W.D., Adolescent cannabis use and adult life chances. Addiction 103 (2008), 977–978.
29. Hall, W.D., What has research over the past two decades revealed about the adverse health effects of recreational cannabis use?. Addiction 110 (2015), 19–35.
30. Hall, W.D., Degenhardt, L., What are the policy implications of the evidence on cannabis and psychosis?. Canadian Journal of Psychiatry 51 (2006), 566–574.
31. Hall, W.D., Degenhardt, L., Adverse health effects of non-medical cannabis use. Lancet 374 (2009), 1383–1391.
32. Hall, W.D., Lynskey, M., Is cannabis a gateway drug? Testing hypotheses about the relationship between cannabis use and the use of other illicit drugs. Drug and Alcohol Review 24 (2005), 39–48.
33. Hall, W.D., Lynske, M., Evaluating the public health impacts of legalizing recreational cannabis use in the United States. Addiction 111 (2016), 1764–1773.
34. Hall, W.D., Lynskey, M., Long-term marijuana use and cognitive impairment in middle age. JAMA Internal Medicine 176 (2016), 362–363.
35. Hall, W.D., Lynskey, M., Why it is probably too soon to assess the public health effects of legalisation of recreational cannabis use in the USA. Lancet Psychiatry 3 (2016), 900–906.
36. Hall, W.D., Pacula, R.L., Cannabis use and dependence: Public health and public policy. 2010, Cambridge University Press, Cambridge, UK (Reissue of first (2003) ed.).
37. Hall, W.D., Room, R., Assessing the wisdom of funding DrinkWise. Medical Journal of Australia 185 (2006), 635–636.
38. Hall, W.D., Room, R., Bondy, S., Comparing the health and psychological risks of alcohol, cannabis, nicotine and opiate use. Kalant, H., Corrigal, W., Hall, W.D., Smart, R., (eds.) The health effects of cannabis, 1999, Centre for Addiction and Mental Health, Toronto, 475–506.
39. Hall, W.D., Renström, M., Poznyak, V., The health and social effects of nonmedical cannabis use., 2016, World Health Organization, Geneva Retrieved 20 May 2016 from http://www.who.int/substance_abuse/publications/msb_cannabis_report.pdf.
40. Heyman, G.M., Quitting drugs: Quantitative and qualitative features. Annual Review of Clinical Psychology 9 (2013), 29–59.
41. Hickman, M., Vickerman, P., Macleod, J., Lewis, G., Zammit, S., Kirkbride, J., Jones, P., If cannabis caused schizophrenia—How many cannabis users may need to be prevented in order to prevent one case of schizophrenia? England and Wales calculations. Addiction 104 (2009), 1856–1861.
42. Huang, Y.H., Zhang, Z.F., Tashkin, D.P., Feng, B., Straif, K., Hashibe, M., An epidemiologic review of marijuana and cancer: An update. Cancer Epidemiology, Biomarkers and Prevention 24 (2015), 15–31.
43. Imtiaz, S., Shield, K.D., Roerecke, M., Cheng, J., Popova, S., Kurdyak, P., et al. The burden of disease attributable to cannabis use in Canada in 2012. Addiction 111 (2016), 653–662.
44. James, T., The failed promise of legal pot. 2016, The Atlantic Retrieved May 26, 2016 from http://www.theatlantic.com/politics/archive/2016/05/legal-pot-and-the-black-market/481506/.
45. Jouanjus, E., Leymarie, F., Tubery, M., Lapeyre-Mestre, M., Cannabis-related hospitalizations: Unexpected serious events identified through hospital databases. British Journal of Clinical Pharmacology 71 (2011), 758–765.
46. Jouanjus, E., Lapeyre-Mestre, M., Micallef, J., Cannabis use: Signal of increasing risk of serious cardiovascular disorders. Journal of the American Heart Association, 3, 2014, e000638.
47. Kalant, H., Corrigal, W., Hall, W.D., Smart, R., The health effects of cannabis. 1999, Centre for Addiction and Mental Health, Toronto.
48. Kandel, D., Kandel, E., The gateway hypothesis of substance abuse: Developmental, biological and societal perspectives. Acta Paediatrica 104 (2015), 130–137.
49. Katcher, B.S., The post-repeal eclipse in knowledge about the harmful effects of alcohol. Addiction 88 (1993), 729–744.
50. Lim, S.S., Vos, T., Flaxman, A.D., Danaei, G., Shibuya, K., Adair-Rohani, H., et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 380 (2012), 2224–2260.
51. Loflin, M., Earleywine, M., A new method of cannabis ingestion: The dangers of dabs?. Addictive Behaviors 39 (2014), 1430–1433.
52. Macleod, J., Oakes, R., Copello, A., Crome, I., Egger, M., Hickman, M., et al. Psychological and social sequelae of cannabis and other illicit drug use by young people: A systematic review of longitudinal general population studies. Lancet 363 (2004), 1579–1588.
53. Mandel, L.L., Bialous, S.A., Glantz, S.A., Avoiding “truth”: Tobacco industry promotion of life skills training. Journal of Adolescent Health 39 (2006), 868–879.
54. Marijuana Policy Project, Consume responsibly: Know the law. 2014 Retrieved 14 June 2016 from http://www.consumeresponsibly.org/law/.
55. Martin, G.W., Rehm, J., The effectiveness of psychosocial modalities in the treatment of alcohol problems in adults: A review of the evidence. Canadian Journal of Psychiatry 57 (2012), 350–358.
56. McLaren, J., Swift, W., Dillon, P., Allsop, S., Cannabis potency and contamination: A review of the literature. Addiction 103 (2008), 1100–1109.
57. Meier, M., Caspi, A., Ambler, A., Harrington, H., Houts, R., Keefe, R., et al. Persistent cannabis users show neuropsychological decline from childhood to midlife. Proceedings of the National Academy of Sciences of the United States of America 109 (2012), E2657–2664.
58. Meier, M., Hall, W., Caspi, A., Belsky, D.W., Cerda, M., Harrington, H.L., et al. Which adolescents develop persistent substance dependence in adulthood? Using population-representative longitudinal data to inform universal risk assessment. Psychological Medicine 46 (2016), 877–889.
59. Miech, R., Koester, S., Trends in U.S. past-year marijuana use from 1985 to 2009: An age-period-cohort analysis. Drug and Alcohol Dependence 124 (2012), 259–267.
60. Monte, A.A., Zane, R.D., Heard, K.J., The implications of marijuana legalization in Colorado. JAMA 313 (2015), 241–242.
61. Moore, T., Zammit, S., Lingford-Hughes, A., Barnes, T., Jones, P., Burke, M., Lewis, G., Cannabis use and risk of psychotic or affective mental health outcomes: A systematic review. Lancet 370 (2007), 319–328.
62. Morral, A., McCaffrey, D., Paddock, S., Reassessing the marijuana gateway effect. Addiction 97 (2002), 1493–1504.
63. Naghavi, M., Wang, H., Lozano, R., Davis, A., Liang, X., Zhou, M., et al. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet 385 (2015), 117–171.
64. Pacula, R.L., Powell, D., Heaton, P., Sevigny, E.L., Assessing the effects of medical marijuana laws on marijuana use: The devil is in the details. Journal of Policy Analysis and Management, 34, 2015.
65. Pardo, B., Cannabis policy reforms in the Americas: A comparative analysis of Colorado, Washington, and Uruguay. International Journal of Drug Policy 25 (2014), 727–735.
66. Parry, C.D., Patra, J., Rehm, J., Alcohol consumption and non-communicable diseases: Epidemiology and policy implications. Addiction 106 (2011), 1718–1724.
67. Patel, R., Wilson, R., Jackson, R., Ball, M., Shetty, H., Broadbent, M., Bhattacharyya, S., Association of cannabis use with hospital admission and antipsychotic treatment failure in first episode psychosis: An observational study. BMJ Open, 6, 2016, e009888.
68. Pierre, J.M., Gandal, M., Son, M., Cannabis-induced psychosis associated with high potency wax dabs. Schizophrenia Research 172 (2016), 211–212.
69. Ramo, D.E., Delucchi, K.L., Hall, S.M., Liu, H., Prochaska, J.J., Marijuana and tobacco co-use in young adults: Patterns and thoughts about use. Journal of Studies on Alcohol and Drugs 74 (2013), 301–310.
70. Rehm, J., Mathers, C., Popova, S., Thavorncharoensap, M., Teerawattananon, Y., Patra, J., Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders. Lancet 373 (2009), 2223–2233.
71. Rehm, J., Baliunas, D., Borges, G.L.G., Graham, K., Irving, H., Kehoe, T., et al. The relation between different dimensions of alcohol consumption and burden of disease: An overview. Addiction 105 (2010), 817–843.
72. Rehm, J., Marmet, S., Anderson, P., Gual, A., Kraus, L., Nutt, D.J., et al. Defining substance use disorders: Do we really need more than heavy use?. Alcohol and Alcoholism 48 (2013), 633–640.
73. Rehm, J., Shield, K.D., Global alcohol-attributable deaths from cancer, liver cirrhosis: and injury in 2010. Alcohol Research: Current Reviews 35 (2013), 174–183.
74. Retail Marijuana Public Health Advisory Committee, Monitoring health concerns related to marijuana in Colorado: 2014 changes in marijuana use patterns, systematic literature review, and possible marijuana-related health effects. 2015, Colorado Department of Public Health and Environment, Boulder Retrieved 26 May 2016 from https://www.colorado.gov/pacific/cdphe/monitoring-marijuana-related-health-effects.
75. Rogeberg, O., Correlations between cannabis use and IQ change in the Dunedin cohort are consistent with confounding from socioeconomic status. Proceedings of the National Academy of Sciences of the United States of America 110 (2013), 4251–4254.
76. Room, R., Fischer, B., Hall, W.D., Lenton, S., Reuter, P., Cannabis policy: Moving beyond stalemate. 2010, Oxford University Press, Oxford.
77. Rosenbaum, M., New perspectives on drug education/prevention. Journal of Psychoactive Drugs 48 (2016), 28–30.
78. Rubinstein, M.L., Rait, M.A., Prochaska, J.J., Frequent marijuana use is associated with greater nicotine addiction in adolescent smokers. Drug and Alcohol Dependence 141 (2014), 159–162.
79. SAMHSA, Behavioral health trends in the United States: Results from the 2014 National Survey on Drug Use and Health HHS Publication No. SMA 15-4927, NSDUH Series H-50. 2015, SAMHSA Center for Behavioral Health Statistics and Quality, Rockville, MD Retrieved 13 March 2016 from http://www.samhsa.gov/data/sites/default/files/NSDUH-FRR1-2014/NSDUH-FRR1-2014.pdf.
80. Sarvet, A.L., Hasin, D., The natural history of substance use disorders. Current Opinion in Psychiatry 29 (2016), 250–257.
81. Shield, K.D., Parry, C., Rehm, J., Chronic diseases and conditions related to alcohol use. Alcohol Research: Current Reviews 35 (2013), 155–173.
82. Sidney, S., Cardiovascular consequences of marijuana use. Journal of Clinical Pharmacology 42 (2002), 64S–70S.
83. Stogner, J.M., Miller, B.L., Assessing the dangers of dabbing: Mere marijuana or harmful new trend?. Pediatrics 136 (2015), 1–3.
84. Tashkin, D., Effects of cannabis on the respiratory system. Kalant, H., Corrigall, W., Hall, W.D., Smart, R., (eds.) The health effects of cannabis, 1999, Centre for Addiction and Mental Health, Toronto, 311–345.
85. Tashkin, D., Increasing cannabis use: What we still need to know about its effects on the lung. Respirology 19 (2014), 619–620.
86. Taylor, D.R., Poulton, R., Moffitt, T., Ramankutty, P., Sears, M., The respiratory effects of cannabis dependence in young adults. Addiction 95 (2000), 1669–1677.
87. van Amsterdam, J., Brunt, T., van den Brink, W., The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like effects. Journal of Psychopharmacology 29 (2015), 254–263.
88. van der Pol, P., Liebregts, N., Brunt, T., van Amsterdam, J., de Graaf, R., Korf, D.J., et al. Cross-sectional and prospective relation of cannabis potency, dosing and smoking behaviour with cannabis dependence: An ecological study. Addiction 109 (2014), 1101–1109.
89. Volkow, N.D., Swanson, J.M., Evins, A.E., DeLisi, L.E., Meier, M.H., Gonzalez, R., et al. Effects of cannabis use on human behavior, including cognition, motivation: and psychosis: A review. JAMA Psychiatry 73 (2016), 292–297.
90. Vos, T., Barber, R., Bell, B., Bertozzi-Villa, A., Biryukov, S., Bolinger, I.,.. GBD 2013 Mortality and Causes of Death Collaborators, Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet 386 (2015), 743–800.
91. Wagenaar, A.C., Tobler, A.L., Komro, K.A., Effects of alcohol tax and price policies on morbidity and mortality: a systematic review. American Journal of Public Health 100 (2010), 2270–2278.
92. Whiteford, H.A., Degenhardt, L., Rehm, J., Baxter, A.J., Ferrari, A.J., Erskine, H.E., et al. Global burden of disease attributable to mental and substance use disorders: Findings from the Global Burden of Disease Study 2010. Lancet 382 (2013), 1575–1586.
93. Wolff, V., Lauer, V., Rouyer, O., Sellal, F., Meyer, N., Raul, J.S., et al. Cannabis use, ischemic stroke, and multifocal intracranial vasoconstriction: A prospective study in 48 consecutive young patients. Stroke 42 (2011), 1778–1780.
94. Wolff, V., Armspach, J.P., Lauer, V., Rouyer, O., Ducros, A., Marescaux, C., Geny, B., Ischaemic strokes with reversible vasoconstriction and without thunderclap headache: A variant of the reversible cerebral vasoconstriction syndrome?. Cerebrovascular Diseases 39 (2015), 31–38.